Corcept Therapeutics, Inc. (CORT) Posts Narrower than Expected Q2 Loss of 9c/Share
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $110.51 -1.49%
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Basic and diluted net loss per share: 0.02
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
For earnings history and earnings-related data on Corcept Therapeutics, Inc. (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- zSpace, Inc. (ZSPC) Reports Q2 results
Create E-mail Alert Related Categories
Earnings, Trading HaltsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
